Kania, K. et al. 2023. FDA Approves Omaveloxolone based on Successful Moxie Trial Results for Friedreich’s Ataxia - Review. Journal of Education, Health and Sport. 40, 1 (Aug. 2023), 111–126. DOI:https://doi.org/10.12775/JEHS.2023.40.01.010.